Mark Pellett is currently the Executive Director and Section Head of Regulatory CMC at AstraZeneca. With a background as a pharmacist and advanced degrees including a PhD in Pharmaceutical Sciences and an MSc in Theory and Application of Computation, Mark has extensive experience in regulatory affairs in the pharmaceutical industry. Previously, Mark held positions at Biogen Idec, GlaxoSmithKline, Pfizer Consumer Healthcare, and Shire Pharmaceuticals, where they led CMC regulatory strategies and managed teams across various projects. Mark's experience spans the development and registration of pharmaceutical products globally, including innovative therapies for serious health conditions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices